Category: Life Sciences
Global Life Sciences
-
Central Venous Catheters (CVCs)
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Multi-Lumen CVCs, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$971.4 Million by the ... Read More
-
Digital Therapeutics
... CAGR of 27.9% over the analysis period 2024-2030. B2B Sales Channel, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$32.9 Billion by the end of the ... Read More
-
ePRO, E-Patient Diaries and eCOA
... Billion by 2030, growing at a CAGR of 15.4% over the analysis period 2024-2030. eClinical Outcome Assessments (eCOAs), one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach ... Read More
-
Infection Surveillance Solutions
... at a CAGR of 16.3% over the analysis period 2024-2030. Infection Surveillance Software, one of the segments analyzed in the report, is expected to record a 15.6% CAGR and reach US$1.3 Billion by the end ... Read More
-
Long-Term Care Software
... at a CAGR of 10.8% over the analysis period 2024-2030. Electronic Health Records (EHR), one of the segments analyzed in the report, is expected to record a 10.8% CAGR and reach US$5.8 Billion by the ... Read More
-
Medical Device Reprocessing
... at a CAGR of 15.3% over the analysis period 2024-2030. Reprocessing Support & Services, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$3.7 Billion by the ... Read More
-
Patient Warming Devices
... at a CAGR of 6.1% over the analysis period 2024-2030. Surface Warming Systems, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.3 Billion by the end ... Read More
-
Surgical Loupes and Cameras
... 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Surgical Loupes, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$443.8 Million by the ... Read More
-
Trampolines
... 5.2% over the analysis period 2024-2030. Round Trampolines, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth ... Read More
-
Otoscopes
... 4.0% over the analysis period 2024-2030. Pocket-Size Otoscopes, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$150.5 Million by the end of the analysis period. Growth ... Read More
-
Special Purpose Needles
... at a CAGR of 6.7% over the analysis period 2024-2030. Hypodermic Needles, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$6.9 Billion by the end of ... Read More
-
Medical Thermometers
... CAGR of 6.9% over the analysis period 2024-2030. Digital Thermometers, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$1.4 Billion by the end of the analysis ... Read More
-
Laboratory Refrigerators and Ovens
... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. General Purpose Laboratory Refrigerators, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$656.3 Million ... Read More
-
Bipolar Disorder Therapeutics
... at a CAGR of 3.4% over the analysis period 2024-2030. Antipsychotic Drugs, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
Calibration Services
... CAGR of 5.6% over the analysis period 2024-2030. Electrical Calibration Services, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Acute Myeloid Leukemia (AML) Therapeutics
... Billion by 2030, growing at a CAGR of 13.3% over the analysis period 2024-2030. Cytarabine, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$592.7 Million by ... Read More
-
RFID in Healthcare
... at a CAGR of 14.6% over the analysis period 2024-2030. RFID Tags, one of the segments analyzed in the report, is expected to record a 16.1% CAGR and reach US$8.5 Billion by the end of ... Read More
-
Biopharmaceutical Bioseparation Systems
... at a CAGR of 10.9% over the analysis period 2024-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$15.8 Billion by the end of ... Read More
-
Compression Therapy
... CAGR of 6.8% over the analysis period 2024-2030. Compression Bandages, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$1.9 Billion by the end of the analysis ... Read More
-
Home Healthcare Software
... at a CAGR of 14.1% over the analysis period 2024-2030. Home Healthcare Solutions, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$6.4 Billion by the end ... Read More
-
Immune Health Supplements
... at a CAGR of 8.5% over the analysis period 2024-2030. Vitamins, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$13.1 Billion by the end of the ... Read More
-
Biocompatible Materials
... CAGR of 15.7% over the analysis period 2024-2030. Polymeric Materials, one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$231.0 Billion by the end of the analysis ... Read More
-
Automotive Adaptive Cruise Control
... 2030, growing at a CAGR of 4.9% over the analysis period 2024-2030. RADAR, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$44.8 Billion by the end ... Read More
-
3D Medical Imaging
... at a CAGR of 6.1% over the analysis period 2024-2030. CT Devices, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$8.9 Billion by the end of ... Read More
-
Animal Genetics
... CAGR of 5.8% over the analysis period 2024-2030. Live Animals, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$7.3 Billion by the end of the analysis ... Read More